Inhowation GmbH acts as the strategic holding company for the InfectoPharm Group, which specializes in the development and marketing of pharmaceuticals and medical products. The operational focus lies on pediatric preparations as well as the therapeutic areas of infectious diseases, pulmonology, dermatology, and ENT. The product portfolio includes prescription (Rx) and over-the-counter (OTC) drugs, medical devices, cosmetics, and dietary supplements. In addition to the core brand InfectoPharm, the group includes specialized subsidiaries such as Paul W. Beyvers GmbH for contract manufacturing and Sonormed GmbH for digital health solutions.
- auf eigenen Namen und eigene Rechnung - die Gründung und der Erwerb sowie die Beteiligung an Unternehmen, die Veräußerung von Unternehmen und Beteiligungen hieran, die Übernahme der Geschäftsführung dieser Unternehmen, die Verwaltung der Beteiligungen an Unternehmen, die Führung und Entwicklung des Konzerns und seiner Konzernunternehmen, das Erbringen zentraler Dienstleistungen innerhalb des Konzerns sowie die Verwaltung eigenen Vermögens
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 105123 (as of 5 November 2026)
| Name | Type | City |
|---|---|---|
| Anna Gilster | Geschäftsführer(in) | Weinheim |
| Philipp Zöller | Geschäftsführer(in) | Darmstadt |
| Company | Location |
|---|---|
| Heppenheim (Bergstraße) | |
| Heppenheim | |
| Berlin |
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 105123 (as of 5 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 21.06.2023 | Company Name Registered | Inhowation GmbH |
| 21.06.2023 | Registered Seat | Heppenheim |
| 21.06.2023 | Business Address Registered | Von-Humboldt-Str. 1, 64646 Heppenheim |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 21.06.2023 | Share Capital Set | — | 36.000 € |
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 105123 (as of 5 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €300,132,350 | €86,024,456 | €516,691,343 | 479 |
| 2023 | €279,033,426 | €67,488,114 | €502,708,625 | 426 |
| 2022 | €250,877,022 | €63,875,043 | €430,943,557 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 105123 (as of 5 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €36,296,758 | 24.5% |
| Material Costs | €90,949,697 | 61.3% |
| Depreciation | €20,955,356 | 14.1% |
| Interest & Similar | €101,499 | 0.1% |
